The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride
- PMID: 23167711
- DOI: 10.1111/add.12066
The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride
Abstract
Aims: Pathological gambling (PG) shares diagnostic features with substance use disorder (SUD), but the neurochemical mechanisms underlying PG are poorly understood. Because dopamine (DA), a neurotransmitter implicated in reward and reinforcement, is probably involved, we used positron emission tomography (PET) to test whether PG is associated with abnormalities in D2 and D3 receptor levels, as observed in SUD.
Design: Case-control study comparing PG to healthy control (HC) subjects.
Setting: Academic research imaging centre.
Participants: Thirteen non-treatment-seeking males meeting DSM-IV criteria for PG, and 12 matched HC (11 of whom completed PET).
Measurements: Two PET scans (one with the D3 receptor preferring agonist [11C]-(+)-propyl-hexahydro-naphtho-oxazin (PHNO) and the other with [11C]raclopride) to assess D(2/3) DA receptor availability, and behavioural measures (self-report questionnaires and slot-machine game) to assess subjective effects and relationships to PET measures.
Findings: Binding of both radiotracers did not differ between groups in striatum or substantia nigra (SN) (all P > 0.1). Across PG, [11C]-(+)-PHNO binding in SN, where the signal is attributable primarily to D3 receptors, correlated with gambling severity (r = 0.57, P = 0.04) and impulsiveness (r = 0.65, P = 0.03). In HC, [11C]raclopride binding in dorsal striatum correlated inversely with subjective effects of gambling (r = -0.70, P = 0.03) and impulsiveness (r = -0.70, P = 0.03).
Conclusions: Unlike with substance use disorder, there appear to be no marked differences in D2 /D3 levels between healthy subjects and pathological gamblers, suggesting that low receptor availability may not be a necessary feature of addiction. However, relationships between [11C]-(+)-PHNO binding and gambling severity/impulsiveness suggests involvement of the D3 receptor in impulsive/compulsive behaviours.
© 2012 The Authors, Addiction © 2012 Society for the Study of Addiction.
Comment in
-
Commentary on Boileau et al. (2013): Distinguishing D2/D3 dopaminergic contributions to addictions.Addiction. 2013 May;108(5):964-5. doi: 10.1111/add.12119. Addiction. 2013. PMID: 23587083 Free PMC article. No abstract available.
Similar articles
-
Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo.Synapse. 2006 Dec 1;60(7):485-95. doi: 10.1002/syn.20325. Synapse. 2006. PMID: 16952157
-
Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study.J Neurosci. 2012 Jan 25;32(4):1353-9. doi: 10.1523/JNEUROSCI.4371-11.2012. J Neurosci. 2012. PMID: 22279219 Free PMC article.
-
[¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders.Mov Disord. 2015 Feb;30(2):160-6. doi: 10.1002/mds.26135. Epub 2015 Jan 14. Mov Disord. 2015. PMID: 25641350
-
[11C](+)-4-N-Propyl-,3,4a,5,6,10b-hexahydro-2H-naphth[1,2-b][1,4]-oxazin-9-ol.2006 May 2 [updated 2011 Oct 6]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2006 May 2 [updated 2011 Oct 6]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641608 Free Books & Documents. Review.
-
Challenges in the development of dopamine D2- and D3-selective radiotracers for PET imaging studies.J Labelled Comp Radiopharm. 2018 Mar;61(3):291-298. doi: 10.1002/jlcr.3558. Epub 2017 Sep 26. J Labelled Comp Radiopharm. 2018. PMID: 28857231 Review.
Cited by
-
Serotonergic and dopaminergic control of impulsivity in gambling disorder.Addict Biol. 2023 Feb;28(2):e13264. doi: 10.1111/adb.13264. Addict Biol. 2023. PMID: 36692875 Free PMC article.
-
Life Habits and Mental Health: Behavioural Addiction, Health Benefits of Daily Habits, and the Reward System.Front Psychiatry. 2022 Jan 27;13:813507. doi: 10.3389/fpsyt.2022.813507. eCollection 2022. Front Psychiatry. 2022. PMID: 35153878 Free PMC article. Review.
-
Unlucky punches: the vulnerability-stress model for the development of impulse control disorders in Parkinson's disease.NPJ Parkinsons Dis. 2021 Dec 8;7(1):112. doi: 10.1038/s41531-021-00253-z. NPJ Parkinsons Dis. 2021. PMID: 34880241 Free PMC article. Review.
-
Increased risk for developing gambling disorder under the treatment with pramipexole, ropinirole, and aripiprazole: A nationwide register study in Sweden.PLoS One. 2021 Jun 1;16(6):e0252516. doi: 10.1371/journal.pone.0252516. eCollection 2021. PLoS One. 2021. PMID: 34061895 Free PMC article.
-
Relationship between regional gray matter volumes and dopamine D2 receptor and transporter in living human brains.Hum Brain Mapp. 2021 Aug 15;42(12):4048-4058. doi: 10.1002/hbm.25538. Epub 2021 May 20. Hum Brain Mapp. 2021. PMID: 34014611 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
